|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 5/06 | (2006.01) |
| A61K 38/55 | (2006.01) | ||
| C07K 5/08 | (2006.01) | ||
| C07K 5/10 | (2006.01) |
| (11) | Number of the document | 1948678 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06837164.0 |
| Date of filing the European patent application | 2006-11-09 | |
| (97) | Date of publication of the European application | 2008-07-30 |
| (45) | Date of publication and mention of the grant of the patent | 2013-05-01 |
| (46) | Date of publication of the claims translation | 2013-09-25 |
| (86) | Number | PCT/US2006/043503 |
| Date | 2006-11-09 |
| (87) | Number | WO 2007/056464 |
| Date | 2007-05-18 |
| (30) | Number | Date | Country code |
| 736118 P | 2005-11-09 | US | |
| 842582 P | 2006-09-05 | US |
| (72) |
ZHOU, Han-jie, US
SUN, Congcong, M., US
SHENK, Kevin, D., US
LAIDIG, Guy, J., US
|
| (73) |
Onyx Therapeutics, Inc.,
249 East Grand Avenue, South San Francisco, CA 94080,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Junginiai, skirti fermentų slopinimui |
| Compounds for enzyme inhibition |
| Payment date | Validity (years) | Amount | |
| 2018-10-24 | 13 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-11-09 |